JP2022533939A5 - - Google Patents
Info
- Publication number
- JP2022533939A5 JP2022533939A5 JP2021567059A JP2021567059A JP2022533939A5 JP 2022533939 A5 JP2022533939 A5 JP 2022533939A5 JP 2021567059 A JP2021567059 A JP 2021567059A JP 2021567059 A JP2021567059 A JP 2021567059A JP 2022533939 A5 JP2022533939 A5 JP 2022533939A5
- Authority
- JP
- Japan
- Prior art keywords
- solvate
- pharmaceutically acceptable
- acceptable salt
- compound according
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962849534P | 2019-05-17 | 2019-05-17 | |
| US62/849,534 | 2019-05-17 | ||
| US201962907491P | 2019-09-27 | 2019-09-27 | |
| US62/907,491 | 2019-09-27 | ||
| PCT/US2020/032939 WO2020236524A1 (en) | 2019-05-17 | 2020-05-14 | Inhibitors of fibroblast growth factor receptor kinases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533939A JP2022533939A (ja) | 2022-07-27 |
| JP2022533939A5 true JP2022533939A5 (enExample) | 2023-05-08 |
Family
ID=73458745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021567059A Pending JP2022533939A (ja) | 2019-05-17 | 2020-05-14 | 線維芽細胞増殖因子受容体キナーゼの阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230174535A1 (enExample) |
| EP (1) | EP3969442A4 (enExample) |
| JP (1) | JP2022533939A (enExample) |
| CN (1) | CN114127051A (enExample) |
| AU (1) | AU2020278566A1 (enExample) |
| CA (1) | CA3139161A1 (enExample) |
| WO (1) | WO2020236524A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12441707B2 (en) | 2019-12-30 | 2025-10-14 | Tyra Biosciences, Inc. | Indazole compounds |
| US11345681B1 (en) * | 2020-06-05 | 2022-05-31 | Kinnate Biopharma Inc. | Inhibitors of fibroblast growth factor receptor kinases |
| CN116096707A (zh) * | 2020-06-05 | 2023-05-09 | 金耐特生物制药公司 | 成纤维细胞生长因子受体激酶的抑制剂 |
| KR20240119095A (ko) * | 2021-12-08 | 2024-08-06 | 킨네이트 바이오파마 인크. | Fgfr 저해제의 고체 상태 형태 |
| WO2023107870A1 (en) * | 2021-12-08 | 2023-06-15 | Kinnate Biopharma Inc. | Inhibitors of fibroblast growth factor receptor kinases |
| CN120344533A (zh) * | 2022-11-22 | 2025-07-18 | 海思科医药集团股份有限公司 | 一种嘧啶衍生物及其在医药上的应用 |
| AU2024301095A1 (en) * | 2023-07-26 | 2026-03-12 | Khora Spv 1, Llc | Treatment of cancer with a cdk inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2168968B1 (en) * | 2004-04-02 | 2017-08-23 | OSI Pharmaceuticals, LLC | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| GB0428082D0 (en) * | 2004-12-22 | 2005-01-26 | Welcome Trust The Ltd | Therapeutic compounds |
| US7723336B2 (en) * | 2005-09-22 | 2010-05-25 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| US20070078136A1 (en) * | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| WO2007064931A2 (en) * | 2005-12-02 | 2007-06-07 | Bayer Healthcare Llc | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| MY171055A (en) * | 2012-01-19 | 2019-09-23 | Taiho Pharmaceutical Co Ltd | 3,5-disubstituted alkynylbenzene compound and salt thereof |
| GB201503590D0 (en) * | 2015-03-03 | 2015-04-15 | Davis Adrian | Topical formulation |
| PT3279202T (pt) * | 2015-03-31 | 2020-08-31 | Taiho Pharmaceutical Co Ltd | Cristal de composto de alquinilo de benzeno 3,5-dissubstituído |
| US11221750B2 (en) * | 2016-02-12 | 2022-01-11 | Purdue Research Foundation | Manipulating 3D virtual objects using hand-held controllers |
| CN107698593A (zh) * | 2016-08-09 | 2018-02-16 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
| US10685111B2 (en) * | 2016-10-31 | 2020-06-16 | Crowdstrike, Inc. | File-modifying malware detection |
| US11130761B2 (en) * | 2016-12-29 | 2021-09-28 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors |
-
2020
- 2020-05-14 EP EP20810387.9A patent/EP3969442A4/en not_active Withdrawn
- 2020-05-14 JP JP2021567059A patent/JP2022533939A/ja active Pending
- 2020-05-14 AU AU2020278566A patent/AU2020278566A1/en not_active Abandoned
- 2020-05-14 CA CA3139161A patent/CA3139161A1/en active Pending
- 2020-05-14 WO PCT/US2020/032939 patent/WO2020236524A1/en not_active Ceased
- 2020-05-14 US US17/605,127 patent/US20230174535A1/en not_active Abandoned
- 2020-05-14 CN CN202080051864.XA patent/CN114127051A/zh active Pending